Gene × Environment Interactions: From Molecular Mechanisms to Behavior
暂无分享,去创建一个
[1] B. Bradley,et al. Gene × Environment Determinants of Stress- and Anxiety-Related Disorders. , 2016, Annual review of psychology.
[2] A. Serretti,et al. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy , 2012, European Neuropsychopharmacology.
[3] V. Campbell,et al. Tetrahydrocannabinol‐induced neurotoxicity depends on CB1 receptor‐mediated c‐Jun N‐terminal kinase activation in cultured cortical neurons , 2003, British journal of pharmacology.
[4] J. Girault,et al. Cannabinoids activate p38 mitogen‐activated protein kinases through CB1 receptors in hippocampus , 2001, Journal of neurochemistry.
[5] T. Wassink,et al. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia , 2011, Schizophrenia Research.
[6] C. Pariante,et al. The Interface of Stress and the HPA Axis in Behavioural Phenotypes of Mental Illness. , 2014, Current topics in behavioral neurosciences.
[7] A. Hariri,et al. FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity , 2012, Genes, brain, and behavior.
[8] Martin H. Schmidt,et al. Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. , 2009, The international journal of neuropsychopharmacology.
[9] A. Serretti,et al. Interaction between SERTPR and stressful life events on response to antidepressant treatment , 2007, European Neuropsychopharmacology.
[10] D. Picard,et al. The glucocorticoid responses are shaped by molecular chaperones , 2007, Molecular and Cellular Endocrinology.
[11] T. Grange,et al. Glucocorticoid‐induced DNA demethylation and gene memory during development , 2001, The EMBO journal.
[12] J. Romero,et al. Functional neuroanatomy of the endocannabinoid system , 2005, Pharmacology Biochemistry and Behavior.
[13] S. Galea,et al. The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. , 2007, The American journal of psychiatry.
[14] L. Price,et al. Interaction of Childhood Maltreatment with the Corticotropin-Releasing Hormone Receptor Gene: Effects on Hypothalamic-Pituitary-Adrenal Axis Reactivity , 2009, Biological Psychiatry.
[15] G. Alpers,et al. Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing , 2016, Molecular Psychiatry.
[16] E. Binder,et al. Gene–Stress–Epigenetic Regulation of FKBP5: Clinical and Translational Implications , 2016, Neuropsychopharmacology.
[17] M. Kanehisa,et al. FKBP5 is associated with amygdala volume in the human brain and mood state: A voxel-based morphometry (VBM) study , 2016, International journal of psychiatry in clinical practice.
[18] F. Holsboer,et al. FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior , 2011, Biological Psychiatry.
[19] E. R. Sánchez,et al. A New First Step in Activation of Steroid Receptors , 2002, The Journal of Biological Chemistry.
[20] A. Danese,et al. Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis. , 2016, The lancet. Psychiatry.
[21] B. Franke,et al. The serotonin transporter gene polymorphism 5-HTTLPR moderates the effects of stress on attention-deficit/hyperactivity disorder. , 2014, Journal of child psychology and psychiatry, and allied disciplines.
[22] M. Rietschel,et al. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project , 2011, The Pharmacogenomics Journal.
[23] A. Serretti,et al. Pharmacogenetics in major depression: A comprehensive meta-analysis , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[24] Peter Kraft,et al. Finding the missing gene–environment interactions , 2015, European Journal of Epidemiology.
[25] C. Hammen,et al. Sensitizing effect of early adversity on depressive reactions to later proximal stress: Moderation by polymorphisms in serotonin transporter and corticotropin releasing hormone receptor genes in a 20-year longitudinal study , 2014, Development and Psychopathology.
[26] A. Danese,et al. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. , 2011, The American journal of psychiatry.
[27] D. Storm,et al. Hippocampal Neurotoxicity of Δ9-Tetrahydrocannabinol , 1998, The Journal of Neuroscience.
[28] S. Armeli,et al. The 5‐HTTLPR polymorphism moderates the effect of stressful life events on drinking behavior in college students of African descent , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[29] C. Beevers,et al. Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. , 2006, Suicide & life-threatening behavior.
[30] K. Ressler,et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. , 2008, JAMA.
[31] Peter Kraft,et al. Challenges and opportunities in genome-wide environmental interaction (GWEI) studies , 2012, Human Genetics.
[32] P. McGuire,et al. Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence , 2016, Neuroscience & Biobehavioral Reviews.
[33] P. Zandi,et al. Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis , 2014, Psychological Medicine.
[34] N. Freimer,et al. 5‐HTTLPR genotype and anxiety‐related personality traits: A meta‐analysis and new data , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[35] K. Lesch,et al. Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.
[36] Matthew C Keller,et al. A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. , 2011, The American journal of psychiatry.
[37] J. P. Hamilton,et al. Neural Substrates of Increased Memory Sensitivity for Negative Stimuli in Major Depression , 2008, Biological Psychiatry.
[38] Steven Lippmann,et al. Chronic schizophrenia. , 1995, Postgraduate medicine.
[39] Shelley E. Taylor,et al. 5-HTTLPR moderates effects of current life events on neuroticism: Differential susceptibility to environmental influences , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[40] D. Collier,et al. Neurotrophic gene polymorphisms and response to psychological therapy , 2012, Translational Psychiatry.
[41] M. Gill,et al. Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression , 2016, Neuropsychopharmacology.
[42] J. Bukszár,et al. Catechol-O-Methyltransferase Contributes to Genetic Susceptibility Shared Among Anxiety Spectrum Phenotypes , 2008, Biological Psychiatry.
[43] A. Kersting,et al. Serotonergic genes modulate amygdala activity in major depression , 2007, Genes, brain, and behavior.
[44] B. Bradley,et al. Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene , 2009, Front. Behav. Neurosci..
[45] Xianzhang Hu,et al. Interaction between Childhood Trauma and Serotonin Transporter Gene Variation in Suicide , 2007, Neuropsychopharmacology.
[46] Hidehiro Iida,et al. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. , 2006, Brain : a journal of neurology.
[47] Catie Chang,et al. Effects of salience-network-node neurofeedback training on affective biases in major depressive disorder , 2016, Psychiatry Research: Neuroimaging.
[48] P. Muglia,et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. , 2010, The American journal of psychiatry.
[49] Tricia Z. King,et al. STRUCTURAL AND FUNCTIONAL CONNECTIVITY IN POSTTRAUMATIC STRESS DISORDER: ASSOCIATIONS WITH FKBP5 , 2016, Depression and anxiety.
[50] A M McIntosh,et al. Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential , 2008, British journal of pharmacology.
[51] M. Beauregard,et al. Early impact of 5-HTTLPR polymorphism on the neural correlates of sadness , 2010, Neuroscience Letters.
[52] G. Jenkins,et al. A Genomewide Association Study of Citalopram Response in Major Depressive Disorder , 2010, Biological Psychiatry.
[53] R. Bryant,et al. FKBP5 risk alleles and the development of intrusive memories , 2015, Neurobiology of Learning and Memory.
[54] Gerhard Andersson,et al. The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder , 2010, BMC psychiatry.
[55] S. Langenecker,et al. Variation in the Corticotropin-Releasing Hormone Receptor 1 (CRHR1) Gene Influences fMRI Signal Responses during Emotional Stimulus Processing , 2012, The Journal of Neuroscience.
[56] Jay Belsky,et al. For Better and For Worse , 2007 .
[57] D. Cicchetti,et al. Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology , 2011, Development and Psychopathology.
[58] A. Caspi,et al. Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. , 2009, Archives of general psychiatry.
[59] L. Selemon,et al. BA11 FKBP5 expression levels correlate with dendritic spine density in postmortem PTSD and controls , 2015, Neurobiology of Stress.
[60] D. Collier,et al. Therapygenetics: The 5HTTLPR and response to psychological therapy , 2011, Molecular Psychiatry.
[61] B. Merriman,et al. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans , 2004, Molecular Psychiatry.
[62] J. Belsky,et al. Take your mind off it: Coping style, serotonin transporter linked polymorphic region genotype (5-HTTLPR), and children's internalizing and externalizing problems , 2015, Development and Psychopathology.
[63] P. Joyce,et al. Childhood neglect and abuse as predictors of antidepressant response in adult depression , 2009, Depression and anxiety.
[64] Florian Holsboer,et al. The Corticosteroid Receptor Hypothesis of Depression , 2000, Neuropsychopharmacology.
[65] Sven Andréasson,et al. CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts , 1987, The Lancet.
[66] K. Ressler,et al. GENOME‐WIDE ASSOCIATION STUDY (GWAS) AND GENOME‐WIDE BY ENVIRONMENT INTERACTION STUDY (GWEIS) OF DEPRESSIVE SYMPTOMS IN AFRICAN AMERICAN AND HISPANIC/LATINA WOMEN , 2016, Depression and anxiety.
[67] Michael F Egan,et al. A susceptibility gene for affective disorders and the response of the human amygdala. , 2005, Archives of general psychiatry.
[68] M C O'Donovan,et al. The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons , 2006, Molecular Psychiatry.
[69] S. Beach,et al. Prevention effects moderate the association of 5-HTTLPR and youth risk behavior initiation: gene x environment hypotheses tested via a randomized prevention design. , 2009, Child development.
[70] A. Pickles,et al. Annual Research Review: Threats to the validity of child psychiatry and psychology. , 2016, Journal of child psychology and psychiatry, and allied disciplines.
[71] N. Schork,et al. Gene-by-Environment (Serotonin Transporter and Childhood Maltreatment) Interaction for Anxiety Sensitivity, an Intermediate Phenotype for Anxiety Disorders , 2008, Neuropsychopharmacology.
[73] Eliza Congdon,et al. Neural correlates of epigenesis , 2006, Proceedings of the National Academy of Sciences.
[74] L. Fañanás,et al. Psychosis‐inducing effects of cannabis are related to both childhood abuse and COMT genotypes , 2014, Acta psychiatrica Scandinavica.
[75] K. Aitchison,et al. Pharmacogenetics of antidepressant response , 2011, Expert review of neurotherapeutics.
[76] A. Toga,et al. FKBP5 and attention bias for threat: associations with hippocampal function and shape. , 2013, JAMA psychiatry.
[77] E. Rabiner,et al. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date , 2015, European Neuropsychopharmacology.
[78] Stephan Ripke,et al. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. , 2013, The American journal of psychiatry.
[79] R. Straub,et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[80] J. Ormel,et al. Differential susceptibility in youth: evidence that 5-HTTLPR x positive parenting is associated with positive affect ‘for better and worse' , 2011, Translational Psychiatry.
[81] G. Kenis,et al. Therapygenetics: 5-HTTLPR genotype predicts the response to exposure therapy for agoraphobia , 2014, European Neuropsychopharmacology.
[82] Bradley N Gaynes,et al. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. , 2009, Psychiatric services.
[83] S. Kapur. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.
[84] W. Vale,et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .
[85] Georgia Koppe,et al. Interaction of the Serotonin Transporter-Linked Polymorphic Region and Environmental Adversity: Increased Amygdala-Hypothalamus Connectivity as a Potential Mechanism Linking Neural and Endocrine Hyperreactivity , 2012, Biological Psychiatry.
[86] Ahmad R. Hariri,et al. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. , 2010, The American journal of psychiatry.
[87] David Goldman,et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. , 2006, American journal of human genetics.
[88] K. Ressler,et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. , 2008, Archives of general psychiatry.
[89] R. Niesink,et al. Does Cannabidiol Protect Against Adverse Psychological Effects of THC? , 2013, Front. Psychiatry.
[90] R. Ophoff,et al. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val158Met polymorphism , 2013, Schizophrenia Research.
[91] Shelley E. Taylor,et al. Early Family Environment, Current Adversity, the Serotonin Transporter Promoter Polymorphism, and Depressive Symptomatology , 2006, Biological Psychiatry.
[92] C. Nemeroff,et al. The CRF system, stress, depression and anxiety—insights from human genetic studies , 2010, Molecular Psychiatry.
[93] T. Rubino,et al. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models , 2010, British journal of pharmacology.
[94] C. Spencer,et al. Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.
[95] T. Powles,et al. Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. , 2005, Blood.
[96] Bart van der Burg,et al. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. , 2003, The Journal of clinical endocrinology and metabolism.
[97] G. Koob,et al. Corticotropin-releasing factor, norepinephrine, and stress , 1999, Biological Psychiatry.
[98] Kymberly D. Young,et al. Real-Time fMRI Neurofeedback Training of Amygdala Activity in Patients with Major Depressive Disorder , 2014, PloS one.
[99] J. Sanjuán,et al. Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain , 2011, Schizophrenia Research.
[100] N. Wray,et al. Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders , 2015, Neuron.
[101] M. Hauser,et al. An Examination of the Association between 5-HTTLPR, Combat Exposure, and PTSD Diagnosis among U.S. Veterans , 2015, PloS one.
[102] W. Vale,et al. CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.
[103] Avshalom Caspi,et al. Gene-environment interplay and psychopathology: multiple varieties but real effects. , 2006, Journal of child psychology and psychiatry, and allied disciplines.
[104] B. Bradley,et al. Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions , 2012, Nature Neuroscience.
[105] A. Caspi,et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.
[106] M. Rietschel,et al. Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume , 2014, Brain Structure and Function.
[107] K. Ressler,et al. Dexamethasone Treatment Leads to Enhanced Fear Extinction and Dynamic Fkbp5 Regulation in Amygdala , 2016, Neuropsychopharmacology.
[108] M. Owen,et al. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use , 2007, British Journal of Psychiatry.
[109] N. Risch,et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. , 2009, JAMA.
[110] Stephan Ripke,et al. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. , 2009, Archives of general psychiatry.
[111] J. Belsky,et al. Child exposure to serious life events, COMT, and aggression: Testing differential susceptibility theory. , 2015, Developmental psychology.
[112] A. Meyer-Lindenberg,et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.
[113] Bettina Sorger,et al. Real-Time Self-Regulation of Emotion Networks in Patients with Depression , 2012, PloS one.
[114] R. Uher,et al. Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response , 2012, Current Psychiatry Reports.
[115] F. Holsboer,et al. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls , 2008, The European journal of neuroscience.
[116] Thomas Meitinger,et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment , 2004, Nature Genetics.
[117] M. Owen,et al. Cannabis, COMT and psychotic experiences , 2011, British Journal of Psychiatry.
[118] A. Caspi,et al. Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction , 2005, Biological Psychiatry.
[119] J. Potash,et al. Polygenic interactions with environmental adversity in the aetiology of major depressive disorder , 2015, Psychological Medicine.
[120] Yiyun Huang,et al. Serotonin Transporter Availability in Patients with Schizophrenia: A Positron Emission Tomography Imaging Study with [11C]DASB , 2005, Biological Psychiatry.
[121] Birgit Funke,et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study , 2005, Behavioral and Brain Functions.
[122] P. Sullivan,et al. Effect of polygenic risk scores on depression in childhood trauma , 2014, British Journal of Psychiatry.
[123] R. Ophoff,et al. Cannabis use at a young age is associated with psychotic experiences , 2010, Psychological Medicine.
[124] Marcus R. Munafò,et al. Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-Analysis , 2008, Biological Psychiatry.
[125] Claes Wahlestedt,et al. Personalized medicine in psychiatry: problems and promises , 2013, BMC Medicine.
[126] Anja Schmitz,et al. Gene–environment interactions predict cortisol responses after acute stress: Implications for the etiology of depression , 2009, Psychoneuroendocrinology.
[127] Masanori Ichise,et al. Serotonin Transporter Binding in Bipolar Disorder Assessed using [11C]DASB and Positron Emission Tomography , 2006, Biological Psychiatry.
[128] Laura J. Scott,et al. Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder , 2015, American journal of human genetics.
[129] P. Jensen. Catechol O-Methyltransferase Gene Variant and Birth Weight Predict Early-Onset Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder , 2007 .
[130] H. Mayberg,et al. Stuck in a rut: rethinking depression and its treatment , 2011, Trends in Neurosciences.
[131] C. Nemeroff. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. , 1989, The Journal of clinical psychiatry.
[132] Tricia Z. King,et al. FKBP5 Genotype and Structural Integrity of the Posterior Cingulum , 2014, Neuropsychopharmacology.
[133] C. Donaldson,et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[134] P. McGuffin,et al. The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis , 2008, Molecular Psychiatry.
[135] Debashis Ghosh,et al. Correcting systematic inflation in genetic association tests that consider interaction effects: application to a genome-wide association study of posttraumatic stress disorder. , 2014, JAMA psychiatry.
[136] Jay Belsky,et al. Beyond diathesis stress: differential susceptibility to environmental influences. , 2009, Psychological bulletin.
[137] F. Wang,et al. Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders , 2010, Neuroscience Letters.
[138] S Beck,et al. Epigenomics: genome-wide study of methylation phenomena. , 2002, Current issues in molecular biology.
[139] A. Caspi,et al. Protective Effect of CRHR 1 Gene Variants on the Development of Adult Depression Following Childhood Maltreatment Replication and Extension , 2009 .
[140] M. Webster,et al. Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness , 2013, Scientific Reports.
[141] Peter W. Dillingham,et al. An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings , 2014, Behavioural Brain Research.
[142] P. Männistö,et al. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.
[143] C. Nievergelt,et al. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene , 2015, Psychoneuroendocrinology.
[144] M. Stein,et al. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. , 2009, Archives of general psychiatry.
[145] R Plomin,et al. Gene–environment interaction analysis of serotonin system markers with adolescent depression , 2004, Molecular Psychiatry.
[146] E. Binder,et al. Expression and Regulation of the Fkbp5 Gene in the Adult Mouse Brain , 2011, PloS one.
[147] A. Sawa,et al. Environmental Stressors and Epigenetic Control of the Hypothalamic-Pituitary-Adrenal Axis , 2014, Neuroendocrinology.
[148] T. Wassink,et al. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse , 2012, Psychological Medicine.
[149] Major Depressive,et al. A mega-analysis of genome-wide association studies for major depressive disorder , 2016 .
[150] B. Lebowitz,et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.
[151] Jim van Os,et al. Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia , 2011, Biological Psychiatry.
[152] D. Kaufer,et al. Glucocorticoids and the Brain: Neural Mechanisms Regulating the Stress Response. , 2015, Advances in experimental medicine and biology.
[153] A. Serretti,et al. The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes , 2013, Neuroscience & Biobehavioral Reviews.
[154] J. Ballenger. The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation , 2012 .
[155] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[156] J. Manzanares,et al. Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims , 2013, Psychoneuroendocrinology.
[157] U. John,et al. Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample , 2016, Human brain mapping.
[158] A. Caspi,et al. Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. , 2011, Journal of affective disorders.
[159] K. Lesch,et al. Genetic contributions to acute autonomic stress responsiveness in children. , 2012, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.
[160] E. Binder,et al. FKBP5 Allele-Specific Epigenetic Modification in Gene by Environment Interaction , 2015, Neuropsychopharmacology.
[161] E. Weeber,et al. A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51 , 2011, PloS one.
[162] C. Anderson,et al. Association between the serotonin transporter triallelic genotype and eating problems is moderated by the experience of childhood trauma in women. , 2012, The International journal of eating disorders.
[163] Israel Liberzon,et al. Genetic Association Analysis of 300 Genes Identifies a Risk Haplotype in SLC18A2 for Post-traumatic Stress Disorder in Two Independent Samples , 2014, Neuropsychopharmacology.
[164] K. Kendler,et al. Candidate Gene–Environment Interaction Research , 2015, Perspectives on psychological science : a journal of the Association for Psychological Science.
[165] F. Holsboer,et al. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress , 2012, Neuropharmacology.
[166] J. Hettema,et al. Direct, indirect and pleiotropic effects of candidate genes on internalizing disorder psychopathology , 2015, Psychological Medicine.
[167] V. Arango,et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.
[168] K. W. Young,et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety , 2011, Nature.
[169] Walter Heindel,et al. 5-HTTLPR Biases Amygdala Activity in Response to Masked Facial Expressions in Major Depression , 2008, Neuropsychopharmacology.
[170] J. Smoller,et al. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children , 2005, Molecular Psychiatry.
[171] C. Flachskamm,et al. Deficiency of FK506‐binding protein (FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice , 2014, Journal of sleep research.
[172] F. Holsboer,et al. Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties , 2015, The Journal of Neuroscience.
[173] R. van Winkel. Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. , 2011, Archives of general psychiatry.
[174] S. Galea,et al. Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. , 2009, American journal of epidemiology.
[175] F. Holsboer,et al. FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells* , 2005, Journal of Biological Chemistry.
[176] Martin H. Schmidt,et al. Moderating role of FKBP5 genotype in the impact of childhood adversity on cortisol stress response during adulthood , 2014, European Neuropsychopharmacology.